APO RESEARCH · REPORT
Amoxicillin
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Product & engineering
Understand the product.
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Selected research
Market Structure
Global Amoxicillin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
This report provides an overview of the global Amoxicillin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Amoxicillin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amoxicillin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amoxicillin market size, projected growth trends, production technologies, key applications, and end-use industries.
Amoxicillin Segment by Company
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Amoxicillin Segment by Type
Capsule
Tablet
Others
Amoxicillin Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Amoxicillin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amoxicillin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amoxicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amoxicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Others
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Companies covered
- GSK
- Novartis
- Centrient Pharma
- Teva
- Mylan
- Cipla
- NCPC
- United Laboratories
- Sun Pharma
- CSPC
- LKPC
- Hikma
- Dr. Reddy
- HPGC
- Aurubindo
- Meiji Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amoxicillin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amoxicillin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amoxicillin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amoxicillin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amoxicillin Market Dynamics
- 2.1 Amoxicillin Industry Trends
- 2.2 Amoxicillin Industry Drivers
- 2.3 Amoxicillin Industry Opportunities and Challenges
- 2.4 Amoxicillin Industry Restraints
3 Amoxicillin Market by Manufacturers
- 3.1 Global Amoxicillin Revenue by Manufacturers (2021-2026)
- 3.2 Global Amoxicillin Sales by Manufacturers (2021-2026)
- 3.3 Global Amoxicillin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amoxicillin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amoxicillin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amoxicillin Manufacturers, Product Type & Application
- 3.7 Global Amoxicillin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amoxicillin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amoxicillin Players Market Share by Revenue in 2025
- 3.8.3 2025 Amoxicillin Tier 1, Tier 2, and Tier 3
4 Amoxicillin Market by Type
- 4.1 Amoxicillin Type Introduction
- 4.1.1 Capsule
- 4.1.2 Tablet
- 4.1.3 Others
- 4.2 Global Amoxicillin Sales by Type
- 4.2.1 Global Amoxicillin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amoxicillin Sales by Type (2021-2032)
- 4.2.3 Global Amoxicillin Sales Market Share by Type (2021-2032)
- 4.3 Global Amoxicillin Revenue by Type
- 4.3.1 Global Amoxicillin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amoxicillin Revenue by Type (2021-2032)
- 4.3.3 Global Amoxicillin Revenue Market Share by Type (2021-2032)
5 Amoxicillin Market by Application
- 5.1 Amoxicillin Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.1.3 Online Pharmacy
- 5.2 Global Amoxicillin Sales by Application
- 5.2.1 Global Amoxicillin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amoxicillin Sales by Application (2021-2032)
- 5.2.3 Global Amoxicillin Sales Market Share by Application (2021-2032)
- 5.3 Global Amoxicillin Revenue by Application
- 5.3.1 Global Amoxicillin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amoxicillin Revenue by Application (2021-2032)
- 5.3.3 Global Amoxicillin Revenue Market Share by Application (2021-2032)
6 Global Amoxicillin Sales by Region
- 6.1 Global Amoxicillin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amoxicillin Sales by Region (2021-2032)
- 6.2.1 Global Amoxicillin Sales by Region (2021-2026)
- 6.2.2 Global Amoxicillin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amoxicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amoxicillin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amoxicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amoxicillin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amoxicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amoxicillin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amoxicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amoxicillin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amoxicillin Revenue by Region
- 7.1 Global Amoxicillin Revenue by Region
- 7.1.1 Global Amoxicillin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amoxicillin Revenue by Region (2021-2026)
- 7.1.3 Global Amoxicillin Revenue by Region (2027-2032)
- 7.1.4 Global Amoxicillin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amoxicillin Revenue (2021-2032)
- 7.2.2 North America Amoxicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amoxicillin Revenue (2021-2032)
- 7.3.2 Europe Amoxicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amoxicillin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amoxicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amoxicillin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amoxicillin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GSK
- 8.1.1 GSK Company Information
- 8.1.2 GSK Business Overview
- 8.1.3 GSK Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GSK Amoxicillin Product Portfolio
- 8.1.5 GSK Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Amoxicillin Product Portfolio
- 8.2.5 Novartis Recent Developments
- 8.3 Centrient Pharma
- 8.3.1 Centrient Pharma Company Information
- 8.3.2 Centrient Pharma Business Overview
- 8.3.3 Centrient Pharma Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Centrient Pharma Amoxicillin Product Portfolio
- 8.3.5 Centrient Pharma Recent Developments
- 8.4 Teva
- 8.4.1 Teva Company Information
- 8.4.2 Teva Business Overview
- 8.4.3 Teva Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva Amoxicillin Product Portfolio
- 8.4.5 Teva Recent Developments
- 8.5 Mylan
- 8.5.1 Mylan Company Information
- 8.5.2 Mylan Business Overview
- 8.5.3 Mylan Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Mylan Amoxicillin Product Portfolio
- 8.5.5 Mylan Recent Developments
- 8.6 Cipla
- 8.6.1 Cipla Company Information
- 8.6.2 Cipla Business Overview
- 8.6.3 Cipla Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Cipla Amoxicillin Product Portfolio
- 8.6.5 Cipla Recent Developments
- 8.7 NCPC
- 8.7.1 NCPC Company Information
- 8.7.2 NCPC Business Overview
- 8.7.3 NCPC Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 NCPC Amoxicillin Product Portfolio
- 8.7.5 NCPC Recent Developments
- 8.8 United Laboratories
- 8.8.1 United Laboratories Company Information
- 8.8.2 United Laboratories Business Overview
- 8.8.3 United Laboratories Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 United Laboratories Amoxicillin Product Portfolio
- 8.8.5 United Laboratories Recent Developments
- 8.9 Sun Pharma
- 8.9.1 Sun Pharma Company Information
- 8.9.2 Sun Pharma Business Overview
- 8.9.3 Sun Pharma Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sun Pharma Amoxicillin Product Portfolio
- 8.9.5 Sun Pharma Recent Developments
- 8.10 CSPC
- 8.10.1 CSPC Company Information
- 8.10.2 CSPC Business Overview
- 8.10.3 CSPC Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 CSPC Amoxicillin Product Portfolio
- 8.10.5 CSPC Recent Developments
- 8.11 LKPC
- 8.11.1 LKPC Company Information
- 8.11.2 LKPC Business Overview
- 8.11.3 LKPC Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 LKPC Amoxicillin Product Portfolio
- 8.11.5 LKPC Recent Developments
- 8.12 Hikma
- 8.12.1 Hikma Company Information
- 8.12.2 Hikma Business Overview
- 8.12.3 Hikma Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hikma Amoxicillin Product Portfolio
- 8.12.5 Hikma Recent Developments
- 8.13 Dr. Reddy
- 8.13.1 Dr. Reddy Company Information
- 8.13.2 Dr. Reddy Business Overview
- 8.13.3 Dr. Reddy Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Dr. Reddy Amoxicillin Product Portfolio
- 8.13.5 Dr. Reddy Recent Developments
- 8.14 HPGC
- 8.14.1 HPGC Company Information
- 8.14.2 HPGC Business Overview
- 8.14.3 HPGC Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 HPGC Amoxicillin Product Portfolio
- 8.14.5 HPGC Recent Developments
- 8.15 Aurubindo
- 8.15.1 Aurubindo Company Information
- 8.15.2 Aurubindo Business Overview
- 8.15.3 Aurubindo Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Aurubindo Amoxicillin Product Portfolio
- 8.15.5 Aurubindo Recent Developments
- 8.16 Meiji Holdings
- 8.16.1 Meiji Holdings Company Information
- 8.16.2 Meiji Holdings Business Overview
- 8.16.3 Meiji Holdings Amoxicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Meiji Holdings Amoxicillin Product Portfolio
- 8.16.5 Meiji Holdings Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amoxicillin Value Chain Analysis
- 9.1.1 Amoxicillin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amoxicillin Production Mode & Process
- 9.2 Amoxicillin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amoxicillin Distributors
- 9.2.3 Amoxicillin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst